Therapeutics / News

Janux Therapeutics Announces Pricing of Initial Public Offering

Posted on: Jun 11, 2021   |   Posted by: Biotech Mag

LA JOLLA, Calif.--Janux Therapeutics, Inc. , a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the pricing of its initial public...